Trends in the use of bone morphogenetic protein–2 in adult spinal deformity surgery: a 10-year analysis of 54 054 patients
RDLG Ramos, JO Nakhla, N Bhashyam… - International Journal of …, 2018 - ijssurgery.com
ABSTRACT Background: Bone morphogenetic protein–2 (BMP-2) is an available bone graft
option in spinal fusion surgery. The purpose of this study is to investigate the trends of BMP …
option in spinal fusion surgery. The purpose of this study is to investigate the trends of BMP …
Recombinant human bone morphogenetic protein–2 use in adult spinal deformity surgery: comparative analysis and healthcare utilization at 24 months' follow-up
Study Design: Retrospective cohort study. Objective: Recombinant human bone
morphogenetic protein–2 (rhBMP-2) is used to achieve fusion in adult spinal deformity …
morphogenetic protein–2 (rhBMP-2) is used to achieve fusion in adult spinal deformity …
The rise and fall of bone morphogenetic protein 2 throughout the United States
AM Beschloss, CM DiCindio, JS Lombardi… - Clinical spine …, 2022 - journals.lww.com
Study Design: Retrospective Database Study. Objective: Investigate utilization of bone
morphogenetic protein (BMP-2) between 2004 and 2014. Summary of Background Data …
morphogenetic protein (BMP-2) between 2004 and 2014. Summary of Background Data …
The Use of Bone Morphogenetic Protein 2 (BMP-2) in Spine Surgery: Is It Valuable?
L Fernandez, A Petrizzo - Bulletin of the NYU Hospital for Joint …, 2023 - search.proquest.com
Background: Bone morphogenetic protein 2 (BMP-2) is one of the most widely used
biologics in spine surgery. Its osteoinductive properties have been shown since its inception …
biologics in spine surgery. Its osteoinductive properties have been shown since its inception …
Does recombinant human bone morphogenetic protein-2 use in adult spinal deformity increase complications and are complications associated with location of …
S Bess, BG Line, V Lafage, F Schwab, CI Shaffrey… - Spine, 2014 - journals.lww.com
Study Design. Multicenter, prospective analysis of consecutive patients with adult spinal
deformity (ASD). Objective. Evaluate complications associated with recombinant human …
deformity (ASD). Objective. Evaluate complications associated with recombinant human …
Use of recombinant bone morphogenetic protein is associated with reduced risk of reoperation after spine fusion for adult spinal deformity
JC Paul, BS Lonner, S Vira, ID Kaye, TJ Errico - Spine, 2016 - journals.lww.com
Study Design. Retrospective review. Objective. This study follows the inpatient-stay
administrative data that were collected for a cohort of thousands of patients who had spine …
administrative data that were collected for a cohort of thousands of patients who had spine …
Bone morphogenetic protein in adult spinal deformity surgery: a meta-analysis
GW Poorman, CM Jalai, A Boniello, N Worley… - European Spine …, 2017 - Springer
Introduction Since its introduction BMP has been utilized in populations with higher rates of
malunion, such as adult spinal deformity (ASD) patients. Contradictory conclusions exist in …
malunion, such as adult spinal deformity (ASD) patients. Contradictory conclusions exist in …
Epidemiological trends in the utilization of bone morphogenetic protein in spinal fusions from 2002 to 2011
K Singh, SV Nandyala, A Marquez-Lara, SJ Fineberg - Spine, 2014 - journals.lww.com
Study Design. Retrospective database analysis. Objective. A nationwide population-based
database was analyzed to assess the utilization trends of bone morphogenetic protein …
database was analyzed to assess the utilization trends of bone morphogenetic protein …
Cost–utility analysis of rhBMP-2 use in adult spinal deformity surgery
Study Design. Economic modeling of data from a multicenter, prospective registry. Objective.
The aim of this study was to analyze the cost utility of recombinant human bone …
The aim of this study was to analyze the cost utility of recombinant human bone …
Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012
Background context Use of bone morphogenetic protein (BMP) as an adjunct to spinal
fusion surgery proliferated after Food and Drug Administration (FDA) approval in 2002 …
fusion surgery proliferated after Food and Drug Administration (FDA) approval in 2002 …